The recently reported superiority of mechanical thrombectomy to intravenous thrombolytics
has jettisoned endovascular intervention into the forefront of acute ischemic stroke (AIS) …

While intravenous administration of tissue plasminogen activator (tPA) remains the only FDA-
approved treatment modality for acute ischemic stroke, many patients do not meet the …

Background Stent retriever thrombectomy of large-vessel occlusion results in better
outcomes than medical therapy alone. Alternative thrombectomy strategies, particularly a …

Importance The benefits of endovascular revascularization using the contact aspiration
technique vs the stent retriever technique in patients with acute ischemic stroke remain …

Background and Purpose—Thrombectomy, primarily with stent retrievers with or without
adjunctive aspiration, provided clinical benefit across multiple prospective randomized trials …

Background The development of new revascularization devices has improved
recanalization rates and time, but not clinical outcomes. We report a prospectively collected …

Background Endovascular techniques for treatment of large vessel occlusions (LVO) in
patients with acute ischemic stroke (AIS) have advanced in recent years. We report a …

Background Modern stent retriever-based embolectomy for patients with emergent large
vessel occlusion improves outcomes. Techniques aimed at achieving higher rates of …

Background and Purpose: Mechanical thrombectomy (MTB) is a reference treatment for
acute ischemic stroke, with several endovascular strategies currently available. However, no …

Background There is a discrepancy in clinical outcomes and the achieved recanalization
rates with stent retrievers in the endovascular treatment of ischemic stroke. It is our …